TERF1P3

Across TCGA pan-cancer cohorts, TERF1P3 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of TERF1P3’s most consistent transcriptional readouts.

The strongest signal is observed in esophageal carcinoma (ESCA), where TERF1P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TERF1P3 is over-expressed in tumor, although a few such as LUAD show the opposite, repressed pattern.

ESCA, LUAD, and STAD are the cancer types where TERF1P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TERF1P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
ESCA	All	II,III,IV	+0.050	.037	2	view →
LUAD	All	III,IV	−0.044	.017	1	view →
STAD	Male	II,III,IV	+0.040	.027	1	view →
LUSC	All	II,III,IV	+0.013	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

TERF1P3–ESCA

Open the ESCA breakdown →